{"id":4011,"date":"2023-09-14T17:03:52","date_gmt":"2023-09-14T22:03:52","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=publicaciones&p=4011"},"modified":"2025-06-18T16:26:34","modified_gmt":"2025-06-18T21:26:34","slug":"concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america","status":"publish","type":"publicaciones","link":"https:\/\/fifarma.org\/en\/publicaciones\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\/","title":{"rendered":"Concept Paper: Adoption of Novel Clinical Evidentiary Standards for Regulatory Decision-Making for Approvals in Latin America"},"content":{"rendered":"

The landscape of drug development is evolving, and both Health Authorities and Industry are facing unique challenges, as well as opportunities to bring innovative medicines and treatments to patients more quickly. In this context, the unprecedented pace of advances being made in the field of regulatory science is of particular importance.<\/p>\n\n\n\n

Preview<\/a><\/div>\n\n\n\n

<\/p>\n\n

\n\n\t\t\n
    \n\t\t\t <\/ul>\n <\/div>","protected":false},"author":24,"parent":0,"template":"","ano":[41],"idioma":[45],"etiquetas-publicacion":[39],"categoria-publicacion":[35],"class_list":["post-4011","publicaciones","type-publicaciones","status-publish","hentry","ano-41","idioma-english","etiquetas-publicacion-asuntos-regulatorios","categoria-publicacion-articulo-academico"],"yoast_head":"\nConcept Paper: Adoption of Novel Clinical Evidentiary Standards for Regulatory Decision-Making for Approvals in Latin America - FIFARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/en\/publications\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Concept Paper: Adoption of Novel Clinical Evidentiary Standards for Regulatory Decision-Making for Approvals in Latin America\" \/>\n<meta property=\"og:description\" content=\"The landscape of drug development is evolving, and both Health Authorities and Industry are facing unique challenges, as well as opportunities to bring innovative medicines and treatments to patients more quickly. In this context, the unprecedented pace of advances being made in the field of regulatory science is of particular importance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/en\/publications\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-18T21:26:34+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\\\/\",\"name\":\"Concept Paper: Adoption of Novel Clinical Evidentiary Standards for Regulatory Decision-Making for Approvals in Latin America - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"datePublished\":\"2023-09-14T22:03:52+00:00\",\"dateModified\":\"2025-06-18T21:26:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publicaciones\",\"item\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Concept Paper: Adoption of Novel Clinical Evidentiary Standards for Regulatory Decision-Making for Approvals in Latin America\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Concept Paper: Adoption of Novel Clinical Evidentiary Standards for Regulatory Decision-Making for Approvals in Latin America - FIFARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/en\/publications\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\/","og_locale":"en_US","og_type":"article","og_title":"Concept Paper: Adoption of Novel Clinical Evidentiary Standards for Regulatory Decision-Making for Approvals in Latin America","og_description":"The landscape of drug development is evolving, and both Health Authorities and Industry are facing unique challenges, as well as opportunities to bring innovative medicines and treatments to patients more quickly. In this context, the unprecedented pace of advances being made in the field of regulatory science is of particular importance.","og_url":"https:\/\/fifarma.org\/en\/publications\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\/","og_site_name":"FIFARMA","article_modified_time":"2025-06-18T21:26:34+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/publicaciones\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\/","url":"https:\/\/fifarma.org\/publicaciones\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\/","name":"Concept Paper: Adoption of Novel Clinical Evidentiary Standards for Regulatory Decision-Making for Approvals in Latin America - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"datePublished":"2023-09-14T22:03:52+00:00","dateModified":"2025-06-18T21:26:34+00:00","breadcrumb":{"@id":"https:\/\/fifarma.org\/publicaciones\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/publicaciones\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/publicaciones\/concept-paper-adoption-of-novel-clinical-evidentiary-standards-for-regulatory-decision-making-for-approvals-in-latin-america\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Publicaciones","item":"https:\/\/fifarma.org\/publicaciones\/"},{"@type":"ListItem","position":3,"name":"Concept Paper: Adoption of Novel Clinical Evidentiary Standards for Regulatory Decision-Making for Approvals in Latin America"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Latin American Federation of the Pharmaceutical Industry","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/publicaciones\/4011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/publicaciones"}],"about":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/types\/publicaciones"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/media?parent=4011"}],"wp:term":[{"taxonomy":"ano","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/ano?post=4011"},{"taxonomy":"idioma","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/idioma?post=4011"},{"taxonomy":"etiquetas-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/etiquetas-publicacion?post=4011"},{"taxonomy":"categoria-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/categoria-publicacion?post=4011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}